Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2018-10-09 Declaration of Voting R…
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
181009 OutstandingShares_Oct2018_ENG_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "PRESS RELEASE REGULATED INFORMATION" and its primary content is the "DISCLOSURE OF OUTSTANDING VOTING SECURITIES" following the issuance of new shares due to stock option exercises. It explicitly states the total outstanding share capital, voting securities, and potential shares issuable under various plans. This type of announcement, detailing changes in the number of shares outstanding and voting rights, directly relates to capital structure changes and major shareholding notifications. Since the document announces the result of an event (stock option exercise) that impacts the total share count, it fits best under Capital/Financing Update (CAP) or Major Shareholding Notification (MRQ). Given the focus on the total number of shares and voting rights, and the reference to the Belgian Act on the disclosure of major shareholdings, it is a specific disclosure about the capital structure. However, the core action described is the issuance of shares due to option exercise, which is a capital change event. The closest fit among the provided codes for a disclosure about the total number of shares outstanding and changes therein, especially when triggered by option exercises, is 'Share Issue/Capital Change' (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (PSI). It is a specific regulatory disclosure about the share count.
2018-10-09 English
181009 OutstandingShares_Oct2018_NL_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release ('PERSBERICHT') dated October 9, 2018, announcing the 'OPENBAARMAKING VAN UITSTAANDE STEMRECHTVERLENENDE EFFECTEN' (Disclosure of Outstanding Voting Rights). It details the issuance of new shares following option exercises and provides an updated summary of the total outstanding share capital, voting rights, and potential future issuances based on various option plans and agreements. This type of announcement, which reports on changes in the total number of shares and voting rights, directly relates to capital structure changes and share issuance/dilution. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the most appropriate fit, as the core purpose is to update the market on the total number of shares following an issuance event (option exercise). It is not a general financing announcement (CAP) but a specific update on the share count.
2018-10-09 Dutch
Transparency Notification Capfi Delen_11Sept2018.pdf
Major Shareholding Notification Classification · 98% confidence The document is a formal notification written primarily in Dutch, detailing changes in voting rights ('stemrechtverlenende effecten of stemrechten'). Key sections include 'Reden voor de kennisgeving' (Reason for notification), 'Kennisgevingsplichtige personen' (Persons required to notify), and detailed tables showing the 'Vorige kennisgeving' (Previous notification) versus 'Na de transactie' (After the transaction) in terms of voting rights percentages (e.g., 4.87%). This structure is characteristic of mandatory regulatory filings concerning changes in significant shareholdings or voting power, often triggered when a threshold is crossed. This aligns perfectly with the definition of Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2018-09-12 Dutch
180911 TranspNotif_Capfi5_ENG_FINAL.pdf
Director's Dealing Classification · 98% confidence The document is explicitly titled as a 'PRESS RELEASE REGULATED INFORMATION' and announces the receipt of a 'transparency notification' regarding a change in major shareholdings, specifically noting that a holding has decreased below the 5% threshold as per the Belgian Transparency Act. This directly relates to notifications about changes in significant share ownership levels. The filing type 'Major Shareholding Notification' (MRQ) is the most appropriate classification for this content, as it details the specific percentage change and the entity involved in crossing a regulatory threshold.
2018-09-12 English
180911 TranspNotif_Capfi5_NL_FINAL.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled 'PERSBERICHT GEREGLEMENTEERDE INFORMATIE' (Regulated Information Press Release) and explicitly announces the 'Openbaarmaking van een transparantiekennisgeving' (Disclosure of a transparency notification) regarding a change in major shareholding, referencing Article 14 of the Belgian Transparency Law. This content directly relates to notifications about changes in significant share ownership crossing thresholds (3%, 5%, 10%, etc.). This aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is presented as a press release, the core subject matter is the change in holding, not the announcement of a report itself (RPA/RNS).
2018-09-12 Dutch
Biocartis H1 2018 Financial Report ENG_FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Financial report H1 2018' for Biocartis Group NV. It contains a message from the CEO, a responsibility statement, a business review, and condensed consolidated interim financial statements for the period ended 30 June 2018. This meets the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. H1 2018
2018-09-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.